Abstract
Background Hypoplastic left heart syndrome (HLHS) presents diagnostic and prognostic challenges while progressing toward heart failure (HF). Understanding the fetal and neonatal HLHS biomechanics, including novel hydrodynamic parameters, could help better planning of the long-term management of HLHS patients.
Objectives Compare fetal and neonatal HLHS cardiac biomechanics against normal subjects using echocardiography.
Methods We performed a retrospective study of 10 HLHS patients with echocardiograms at 33-weeks gestation and at the first week post-birth and 12 age-matched controls. We used in-house developed analysis algorithms to quantify ventricular biomechanics from four-chamber B-mode and color Doppler scans. Cardiac morphology, hemodynamics, tissue motion, deformation, and flow parameters were measured.
Results Tissue motion, deformation, and index measurements did not reliably capture biomechanical changes. Stroke volume and cardiac output were nearly twice as large for the HLHS right ventricle (RV) compared to the control RV and left ventricle (LV) due to RV enlargement. The enlarged RV exhibited disordered flow with higher energy loss (EL) compared to prenatal control LV and postnatal control RV and LV. Furthermore, the enlarged RV demonstrated elevated vortex strength (VS) compared to both the control RV and LV, prenatally and postnatally. The HLHS RV showed reduced relaxation with increased early filling velocity (E) compared prenatally to the LV and postnatally to the control RV and LV. Furthermore, increased recovery pressure (ΔP) was observed between the HLHS RV and control RV and LV, prenatally and postnatally.
Conclusions The novel hydrodynamic parameters more reliably capture the HLHS alterations in contrast to traditional parameters.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by the Indiana Clinical and Translational Sciences Institute and funded, in part, by Grant Number UL1TR002529 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award and, in part, by Grant Number 1R21HD109490 from the National Institues of Health, National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. No industry partnerships collaborated on or funded this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board for Human Studies for Purdue and Indiana universities and Children's National Hospital approved the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
meyers18{at}purdue.edu, bhattac3{at}purdue.edu, mcb5351{at}psu.edu, d, rpayne{at}iu.edu, pvlachos{at}purdue.edu
This project was supported by the Indiana Clinical and Translational Sciences Institute and funded, in part, by Grant Number UL1TR002529 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award and, in part, by Grant Number 1R21HD109490 from the National Institues of Health, National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. No industry partnerships collaborated on or funded this work.
Brett A. Meyers, Melissa C. Brindise, and Pavlos P. Vlachos have intellectual property filings for each analysis algorithm in the analysis method used in this manuscript. Brett A. Meyers and Pavlos P. Vlachos are involved with Cordian Technologies, a start-up founded by Pavlos P. Vlachos, which licenses the technologies used in this work. R. Mark Payne has a significant interest in Larimar Therapeutics, Inc., which is unrelated to this work. He also has funding from NHLBI as a co-investigator (1P01HL134599), and as site PI on an NHLBI consortium project (UG1HL135678). Y. Loke receives partial salary support from NHLBI (R21-HL156045-01)
Tweet: NEW ARTICLE IN #JACCIMG. New echocardiography tools advance our understanding of congenital heart disease in the fetus. #cvImaging #PedsCards #CHD #CardioTwitter
Manuscript has undergone major revisions since last update. Two collaborators have been added to enlarge the study cohort size and assist in evaluating the data. Introduction has been edited to make the background more succinct and focused on diastolic function of HLHS. Methods have not undergone major changes except for statistical analysis; significance testing is now performed with one-way ANOVA and post-hoc Tukey testing. Results have been updated to present differences in systolic and diastolic function per patient population in the cohort. Figure 2 and Figure 3 revised to demonstrate tissue morphology, deformation, and hydrodynamics differences for both the fetal and neonate cases. Figure 4 has been converted to a table. Discussion focuses further on diastology. Figure 4 has been added to present the differences in hydrodynamics of normal and HLHS hearts.
Data Availability
Data will be made available upon request.
Abbreviations
- AV
- Atrioventricular
- ALAX
- Apical long axis
- CFI
- color flow imaging
- CO
- Cardiac output
- EL
- Energy loss
- HLHS
- Hypoplastic Left Heart Syndrome
- VS
- Vortex strength
- SV
- Stroke volume
- ΔP
- Pressure difference
- IVPD
- Intraventricular pressure difference
